Key market opportunities in cell and gene therapy include tracking investment trends, analyzing key deals, and staying updated with scientific developments… Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE...
Key market opportunities in cell and gene therapy include tracking investment trends, analyzing key deals, and staying updated with scientific developments… Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE...
Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest biotech breakthrough of the century. Yet so far, there’s been only one gene...
Scientists have used CRISPR technology to bring back a long-lost gene that could be used to prevent gout and certain types of liver disease. Researchers have successfully resurrected a gene that human...
Technology stock expert and investor Gene Munster shares 11 predictions for 2026, including what could happen to several Mag 7 stocks. Deepwater Asset Management’s Gene Munster is back with a 10...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time. For a decade after its discovery, CRISPR gene editing was stuck on the cusp of transf...
Apple is reshaping its AI leadership as longtime chief John Giannandrea plans to retire in spring 2026, Amar Subramanya takes over as VP of AI, and CEO Tim Cook intensifies his focus on AI innovation ...
Apple is reshaping its AI leadership as longtime chief John Giannandrea plans to retire in spring 2026, Amar Subramanya takes over as VP of AI, and CEO Tim Cook intensifies his focus on AI innovation ...
Apple is reshaping its AI leadership as longtime chief John Giannandrea plans to retire in spring 2026, Amar Subramanya takes over as VP of AI, and CEO Tim Cook intensifies his focus on AI innovation ...
Apple is reshaping its AI leadership as longtime chief John Giannandrea plans to retire in spring 2026, Amar Subramanya takes over as VP of AI, and CEO Tim Cook intensifies his focus on AI innovation ...
